On September 10, 2026, the three major Hong Kong indices continued to weaken, with the Hang Seng Index down 1.27%, the Hang Seng TECH Index down 2.04%, and the Hang Seng China Enterprises Index down 1.13%. AI concept stocks were generally under pressure on the day, with the large model sector declining across the board, AI chips showing mixed gains and losses, and the intelligent driving and embodied intelligence sectors mostly following the decline.
on September 10, 2026, the three major Hong Kong indices continued to weaken, with the Hang Seng Index down 1.27%, the Hang Seng TECH Index down 2.04%, and the Hang Seng China Enterprises Index down 1.13%. The Hang Seng Index's full-day turnover was 198.9 billion HKD, Southbound funds saw a net inflow of 4.551 billion HKD.
On September 10, 2026, sentiment across the HK shares ETFs market was extremely subdued, with the gainers table looking distinctly anemic. Only a handful of products posted marginal advances, and Ping An of China CSI HK Dividend ETF (03070.HK) and Premia MSCI Vietnam ETF (02804.HK) tied at the top with identical gains of just 0.18%. Five of the ten names on the gainers list closed flat, leaving the market with virtually no income effect. On the downside, biotech and tech/internet themes bore the brunt of concentrated selling pressure: CSOP Hang Seng Biotech ETF (03174.HK) plunged 2.80% to lead the decliners, while Hang Seng TECH and China internet themes broadly weakened. Within the southbound Stock Connect ETF complex, only high-dividend products edged higher while biotech and Hang Seng TECH themes led the decline, broadly in line with the directional tilt of the wider market.
On September 10, 2026, the Shanghai-Shenzhen Stock Connect ETFs market saw large-cap financial themes including banking, financials and securities strengthen collectively, while agriculture, animal husbandry and chemicals sectors faced notable selling pressure and led the decliners.
On September 10, 2026, XPENG-W (09868.HK) traded weaker in the afternoon session. As of 14:01, it was quoted at HK$40.80, down 3.55%.
on September 10, 2026, the chip theme traded with volatility, with HUA HONG GRACE (01347.HK) moving higher. As of 13:55, the company was quoted at HK$113.900, up 2.06%.
on September 10, 2026, the robotics theme fluctuated and weakened, with MIDEA GROUP (00300.HK) bucking the trend to move higher. As of 13:34, the company was quoted at HK$99.150, up 0.51%.
On 9 September 2026, HAND Information (300170.SZ) announced that its board approved the termination of its H-share issuance and planned listing on HKEX, reversing the plan approved by the board and an extraordinary general meeting in December 2025; the company cited the macroeconomic environment, capital market conditions and its own development plans, noted the termination falls within the board's authorized scope without requiring shareholder approval, and stated the decision will not materially affect its operations and sustained development.
as of 10:26 on September 10, 2026, the SSE 180 Financial Stocks Index (000018) rose 0.62%, with the Guotai SSE 180 Finance ETF (510230) last quoted at RMB 1.35.In terms of liquidity, the Guotai SSE 180 Finance ETF recorded an intraday turnover rate of 6.32% and turnover of RMB 57.0489 million. Over a longer horizon, as of September 9, the ETF's average daily turnover over the past week stood at RMB 96.6954 million.
as of 10:17 on September 10, 2026, the CSI Banks Index (399986) rose strongly by 1.21%, with the China Universal CSI Banks ETF (512820) pushing for a third straight gain, last quoted at RMB 1.49.In terms of scale, the ETF's AUM grew by RMB 32.1653 million over the past week, achieving significant growth.In terms of shares, the ETF's shares grew by 21.90 million units over the past week, achieving significant growth.
On 10 September 2026, INSILICO (03696.HK) announced that its AI-driven candidate Rentosertib completed first patient dosing in the Phase III IPF trial GENESIS-IPF-3 at Peking Union Medical College Hospital and Shanghai Pulmonary Hospital on the same day. The 52-week study plans to enroll 320 subjects at 47 Chinese centers with annual FVC decline rate as primary endpoint, led by Professor Xu Zuojun, with Academician Zhong Nanshan and Chen Chang as co-lead investigators.
On 10 September 2026, LIFETECH SCI (01302.HK) announced that the LantvalTM aortic valve replacement system, the world's first sutureless system with a fully preloaded dry-valve design jointly developed with Fuwai Hospital, has entered the NMPA Innovative Medical Device Special Review Procedure, becoming the company's 18th product to do so.
On 10 September 2026, BOC AVIATION (02588.HK) announced the purchase of 12 A320NEO aircraft from Airbus on 9 September 2026 for long-term lease to Colombia's Avianca, with all deliveries planned for 2029. The transactions constitute a discloseable transaction under Chapter 14 but are exempt as qualified aircraft leasing activities.
On 10 September 2026, STAR SPORTS MED (01609.HK) announced that it has become the first Chinese sports medicine manufacturer to obtain full product line EU CE MDR certification across 15 product categories, while product registrations in the UK, Australia, Brazil, Singapore, Malaysia and Thailand have been approved.
On 9 September 2026, AK MEDICAL (01789.HK) announced a new shareholder dividend plan, raising the annual payout ratio to no less than 55% of profit attributable to equity shareholders for FY2026 and no less than 60% for each of FY2027 and FY2028. The plan will be funded by internal resources with no expected material impact on working capital, with implementation at the Board's discretion.
On 10 September 2026, XUNZHONG (02597.HK) announced a placing of 11,190,000 new H shares at HKD 28.20 per share under the general mandate, a 19.43% discount to the previous close, raising net proceeds of approximately HKD 313.64 million.
